Interview with Neurolief about Relivion: Release set for late 2021

We are very excited to be interviewing Neurolief about Relivion, a device that has recently received FDA clearance and is yet to be rolled out to treat migraine. Relivion is a neuromodulation system which is something that we at Innovation in Migraine see as an extremely interesting path for the treatment of migraine – readContinue reading “Interview with Neurolief about Relivion: Release set for late 2021”